Abstract
The Contrast Media Safety Committee of the European Society of Urogenital Radiology (ESUR) has looked at the effects of contrast media (CM) on the kidney including prevention of contrast medium-induced nephropathy (CIN) as well as at the possibility of identifying patients with increased risk of CIN nephropathy. This has resulted in five reports dealing with (i) serum creatinine; (ii) contrast medium-induced nephrotoxicity; (iii) haemodialysis and contrast media; (iv) use of gadolinium CM instead of iodinated CM; and (v) CM injection in diabetic patients receiving metformin. The review presents an overview of four of these five reports.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
